Chemotherapy-induced peripheral neuropathy in the pediatric population: risk factors, assessment strategies and functional outcomes

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Chemotherapy, commonly used for treatment of childhood cancer, can cause peripheral nerve injury with disabling symptoms which may be long lasting. This project aims to provide a comprehensive evaluation of the nerve injury and standardize sensitive ways of measuring nerve function. This is the first study that will follow children throughout their treatment cycle with regular nerve assessments, providing a greater understanding of nerve injury mechanisms and enabling treatment modification.

Funded Activity Details

Start Date: 01-01-2016

End Date: 01-01-2018

Funding Scheme: Postgraduate Scholarships

Funding Amount: $88,766.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Peripheral Nervous System

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

adverse effects | cancer chemotherapeutic agents | cancer follow-up | neurophysiology | peripheral neuropathy